InflaRx N.V 6-K, filed May 11, 2023

InflaRx N.V. (IFRX)

6-K 2023-05-11 For: 2023-05-11

View Original

Added on April 09, 2026

About this 6-K

InflaRx N.V filed this 6-K on May 11, 2023.

Search and read filings like this one from Claude or ChatGPT with the SEC filings MCP server →

Exhibit	Description of Exhibit
99.1	InflaRx N.V. Unaudited Condensed Consolidated Financial Statements as of and for the Three Months Ended March 31, 2023
99.2	InflaRx N.V. Management’s Discussion and Analysis of Financial Condition and Results of Operations
99.3	InflaRx N.V. Press Release, dated May 11, 2023

	INFLARX N.V.

Date: May 11, 2023	By:	/s/ Niels Riedemann
	Name:	Niels Riedemann
	Title:	Chief Executive Officer

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three months ended March 31, 2023 and 2022	3
Unaudited Condensed Consolidated Statements of Financial Position as of March 31, 2023 and December 31, 2022	4
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity for the three months ended March 31, 2023 and 2022	5
Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022	6

1.	Summary of significant accounting policies and other disclosures		7
	a)	Reporting entity and the Group’s structure	7
	b)	Basis of preparation	7
2.	Other income		8
3.	Net financial result		8
4.	Other assets		9
5.	Financial assets and financial liabilities		9
6.	Cash and cash equivalents		10
7.	Equity		10
8.	Share-based payments		10
	a)	Equity settled share-based payment arrangements	10
	b)	Share-based payment expense recognized	10
9.	Protective foundation		11
10.	Subsequent events		12

			For the three months ended March 31,
	Note		2023 (unaudited)			2022 (unaudited)
			(in €, except for share data)
Operating expenses
Research and development expenses				(14,731,908	)		(10,471,923	)
General and administrative expenses				(3,608,554	)		(4,387,443	)
Total operating expenses				(18,340,462	)		(14,859,366	)
Other income		2		7,746,189			1,593
Other expenses				(566	)		(565	)
Operating result				(10,594,839	)		(14,858,338	)
Finance income		3		456,036			27,962
Finance expenses		3		(5,528	)		(24,586	)
Foreign exchange result		3		(1,137,310	)		727,933
Other financial result		3		197,808			125,000
Income taxes				—			—
Loss for the period				(11,083,833	)		(14,002,030	)

Share information
Weighted average number of shares outstanding				44,771,703			44,203,763
Loss per share (basic/diluted)				(0.25	)		(0.32	)

Loss for the period				(11,083,833	)		(14,002,030	)
Other comprehensive income (loss) that may be reclassified to profit or loss in subsequent periods:
Exchange differences on translation of foreign currency				(16,785	)		1,309,875
Total comprehensive loss				(11,100,618	)		(12,692,154	)

	Note		March 31, 2023 (unaudited)			December 31, 2022
			(in €)
ASSETS
Non-current assets
Property and equipment				306,371			328,920
Right-of-use assets				1,214,865			1,311,809
Intangible assets				114,847			138,905
Other assets		4		297,021			308,066
Financial assets		5		7,969,071			2,900,902
Total non-current assets				9,902,175			4,988,602
Current assets
Current other assets		5		5,956,752			14,170,510
Income tax receivable				2,141,785			1,432,087
Financial assets from government grants		5		3,434,047			732,971
Other financial assets		5		62,779,179			64,810,135
Cash and cash equivalents		6		2,097,250			16,265,355
Total current assets				76,409,014			97,411,058
TOTAL ASSETS				86,311,189			102,399,660

EQUITY AND LIABILITIES
Equity
Issued capital		7		5,373,000			5,364,452
Share premium		6		282,668,032			282,552,633
Other capital reserves		7		37,842,612			36,635,564
Accumulated deficit				(254,544,123	)		(243,460,290	)
Other components of equity				7,240,295			7,257,081
Total equity				78,579,816			88,349,440
Non-current liabilities
Lease liabilities				896,331			987,307
Other liabilities				36,877			36,877
Total non-current liabilities				933,208			1,024,184
Current liabilities
Trade and other payables		5		4,616,092			4,987,538
Liabilities from government grants received		5		1,175,487			6,209,266
Lease liabilities				365,457			369,376
Employee benefits				477,535			1,312,248
Other liabilities				163,594			147,608
Total current liabilities				6,798,165			13,026,036
Total liabilities				7,731,373			14,050,220
TOTAL EQUITY AND LIABILITIES				86,311,189			102,399,660

	Note		Shares outstanding		Issued capital		Share premium		Other capital reserves		Accumulated deficit			Other com- ponents of equity			Total equity
Balance as of January 1, 2023				44,703,763		5,364,452		282,552,633		36,635,564		(243,460,290	)		7,257,081			88,349,440
Loss for the period				—		—		—		—		(11,083,833	)		—			(11,083,833	)
Exchange differences on translation of foreign currency				—		—		—		—		—			(16,785	)		(16,785	)
Total comprehensive loss				—		—		—		—		(11,083,833	)		(16,785	)		(11,100,618	)
Equity-settled share-based payments		7		—		—		—		1,207,048		—			—			1,207,048
Share options exercised				71,234		8,548		115,399		—		—			—			123,947
Balance as of March 31, 2023*				44,774,997		5,373,000		282,668,032		37,842,612		(254,544,123	)		7,240,295			78,579,816

Balance as of January 1, 2022				44,203,763		5,304,452		280,310,744		30,591,209		(213,975,679	)		3,050,271			105,280,996
Loss for the period				—		—		—		—		(14,002,030	)		—			(14,002,030	)
Exchange differences on translation of foreign currency				—		—		—		—		—			1,309,875			1,309,875
Total comprehensive loss				—		—		—		—		(14,002,030	)		1,309,875			(12,692,155	)
Equity-settled share-based payments		7		—		—		—		2,530,775		—			—			2,530,775
Balance as of March 31, 2022*				44,203,763		5,304,452		280,310,744		33,121,984		(227,977,709	)		4,360,146			95,119,617

	As of March 31, 2023 (unaudited)		As of December 31, 2022
	(in €)
Non-current other assets
Prepaid expense		297,021		308,066
Total		297,021		308,066
Current other assets
Prepayments on research & development projects		4,438,122		9,776,505
Prepaid expense		1,516,723		1,841,935
Others		1,906		2,552,071
Total		5,956,751		14,170,511
Total other assets		6,253,772		14,478,577

Number of share options	2023		2022
Outstanding as of January 1,		148,433		148,433
Exercised during the three months ended March 31		—		—
Outstanding as of March 31,		148,433		148,433
thereof vested		148,433		148,433

Share options granted 2023	Number		Fair value per option		FX rate as of grant date		Fair value per option		Share price at grant date / Exercise price		Expecte d volatility		Expec ted life (midp oint based)		Risk-free rate (interpolated, U.S. sovereign strips curve)

January 24		1,454,250	$	2.11		0.9008	€	1.90	$	2.37		1.35		5.30		3.571	%
January 24		52,500	$	2.13		0.9008	€	1.92	$	2.37		1.35		5.50		3.565	%
		1,506,750

	Three Months Ended March 31,
	2023			2022			Change
	(in €)
Operating expenses
Research and development expenses		(14,731,908	)		(10,471,923	)		(4,259,985	)
General and administrative expenses		(3,608,554	)		(4,387,443	)		778,889
Total operating expenses		(18,340,462	)		(14,859,366	)		(3,481,096	)
Other income		7,746,189			1,593			7,744,596
Other expenses		(566	)		(565	)		(1	)
Operating result		(10,594,839	)		(14,858,338	)		4,263,499
Finance income		456,036			27,962			428,074
Finance expenses		(5,528	)		(24,586	)		19,058
Foreign exchange result		(1,137,310	)		727,933			(1,865,243	)
Other financial result		197,808			125,000			72,808
Income taxes		—			—			—
Loss for the period		(11,083,833	)		(14,002,030	)		2,918,197
Exchange differences on translation of foreign currency		(16,785	)		1,309,875			(1,326,660	)
Total comprehensive loss		(11,100,618	)		(12,692,154	)		1,591,536

	March 31, 2023 (unaudited)			December 31, 2022
	(in €)
ASSETS
Non-current assets
Property and equipment		306,371			328,920
Right-of-use assets		1,214,865			1,311,809
Intangible assets		114,847			138,905
Other assets		297,021			308,066
Financial assets		7,969,071			2,900,902
Total non-current assets		9,902,175			4,988,602
Current assets
Current other assets		5,956,752			14,170,510
Income tax receivable		2,141,785			1,432,087
Financial assets from government grants		3,434,047			732,971
Other financial assets		62,779,179			64,810,135
Cash and cash equivalents		2,097,250			16,265,355
Total current assets		76,409,014			97,411,058
TOTAL ASSETS		86,311,189			102,399,660

EQUITY AND LIABILITIES
Equity
Issued capital		5,373,000			5,364,452
Share premium		282,668,032			282,552,633
Other capital reserves		37,842,612			36,635,564
Accumulated deficit		(254,544,123	)		(243,460,290	)
Other components of equity		7,240,295			7,257,081
Total equity		78,579,816			88,349,440
Non-current liabilities
Lease liabilities		896,331			987,307
Other liabilities		36,877			36,877
Total non-current liabilities		933,208			1,024,184
Current liabilities
Trade and other payables		4,616,092			4,987,538
Liabilities from government grants received		1,175,487			6,209,266
Lease liabilities		365,457			369,376
Employee benefits		477,535			1,312,248
Other liabilities		163,594			147,608
Total current liabilities		6,798,165			13,026,036
Total liabilities		7,731,373			14,050,220
TOTAL EQUITY AND LIABILITIES		86,311,189			102,399,660